🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 3 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/04/2022 46,00 46,20 44,37 45,76 +0,59% 3,98% 531.300
19/04/2022 44,44 46,10 43,93 45,49 +2,62% 4,88% 502.000
18/04/2022 46,67 46,67 43,95 44,33 -5,42% 5,83% 758.400
14/04/2022 48,89 49,35 46,78 46,87 -4,81% 5,25% 521.800
13/04/2022 46,99 49,50 46,60 49,24 +5,12% 6,17% 699.100
12/04/2022 47,54 48,73 46,08 46,84 +0,11% 5,57% 666.600
11/04/2022 47,50 48,50 46,27 46,79 -3,03% 4,69% 555.800
08/04/2022 49,14 50,01 48,20 48,25 -1,55% 3,68% 627.000
07/04/2022 47,89 49,41 47,86 49,01 +1,81% 3,24% 633.500
06/04/2022 47,49 49,00 46,84 48,14 -0,54% 4,55% 601.300
05/04/2022 50,48 51,11 48,15 48,40 -4,37% 5,86% 729.500
04/04/2022 49,22 50,77 48,42 50,61 +2,87% 4,77% 710.900
01/04/2022 46,16 50,42 46,16 49,20 +6,98% 9,23% 1.032.400
31/03/2022 45,80 47,11 45,76 45,99 +0,88% 2,95% 711.400
30/03/2022 46,41 48,31 45,34 45,59 -2,42% 6,40% 703.200
29/03/2022 45,67 46,96 45,49 46,72 +4,33% 3,22% 650.300
28/03/2022 44,26 46,27 42,90 44,78 +1,52% 7,61% 569.500
25/03/2022 45,36 45,88 43,44 44,11 -6,37% 5,39% 1.246.200
24/03/2022 45,99 47,13 45,60 47,11 +3,36% 3,33% 849.500
23/03/2022 47,37 47,53 45,43 45,58 -4,10% 4,43% 528.400
22/03/2022 45,95 48,02 45,37 47,53 +4,69% 5,76% 695.900
21/03/2022 46,81 46,88 45,00 45,40 -4,18% 4,02% 470.000
18/03/2022 47,00 48,76 46,87 47,38 +1,48% 4,03% 2.023.700
17/03/2022 43,37 46,95 43,00 46,69 +6,79% 9,11% 770.200
16/03/2022 41,70 43,78 41,25 43,72 +7,37% 6,07% 711.500
15/03/2022 40,37 41,44 39,71 40,72 +2,78% 4,29% 663.100
14/03/2022 41,64 42,94 38,89 39,62 -5,17% 9,73% 818.200
11/03/2022 44,00 44,52 41,68 41,78 -3,55% 6,47% 410.900
10/03/2022 43,45 44,32 42,53 43,32 -2,83% 4,12% 345.200
09/03/2022 42,45 44,98 42,31 44,58 +7,86% 6,30% 507.100